Patent · US Active

Antibodies directed to Tie-2 and methods of use

US12195542B2 · kind B2 · utility

0Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 19, 2020
Grant dateJan 14, 2025
Priority date
Expiry dateJul 11, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to anti-Tie2 antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.